Andrew J. Phillips
Angel · Colorado
Board director at 4 startups that filed Form D raises since late 2024, mostly in Colorado.
- Stages
- Series A to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Feb 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: OnKureApr 3, 2023
- SEC Form D: Enliven TherapeuticsApr 3, 2024
- SEC Form D: OnKure TherapeuticsOct 21, 2024
- SEC Form D: Kestrel TherapeuticsFeb 21, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.